Show Summary Details
Page of

Trigeminal interventions for head and neck cancer pain 

Trigeminal interventions for head and neck cancer pain
Trigeminal interventions for head and neck cancer pain

Devjit Srivastava

and Manohar Sharma

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 13 June 2021

Head and neck cancer usually refers to malignant tumours that arise in the mucosa of the oral cavity, pharynx, larynx, nasal cavity, and paranasal sinuses. Pain is a significant problem with head and neck cancers. One study reported an overall pain prevalence of greater than 50% in patients with all cancer types; the highest cancer subtype was head and neck cancer, with a pain prevalence of 70%. Pain may be caused by the cancer itself. Pain can also be caused by cancer invading nerve, muscle, mucosal damage, and tumour pressure. Treatments for cancer like surgery, radiotherapy, and chemotherapy by themselves can also cause pain. One of the commonest manifestations is mucositis-related pain. At times, the pain may be unrelated to cancer and may be myofascial or related to temporomandibular joint dysfunction. Interventional treatments for pain in trigeminal nerve distribution are described in this chapter.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.